MX2021004355A - Moleculas quimericas. - Google Patents
Moleculas quimericas.Info
- Publication number
- MX2021004355A MX2021004355A MX2021004355A MX2021004355A MX2021004355A MX 2021004355 A MX2021004355 A MX 2021004355A MX 2021004355 A MX2021004355 A MX 2021004355A MX 2021004355 A MX2021004355 A MX 2021004355A MX 2021004355 A MX2021004355 A MX 2021004355A
- Authority
- MX
- Mexico
- Prior art keywords
- cell
- chimeric molecules
- tcrs
- vitro
- relates
- Prior art date
Links
- 108091008874 T cell receptors Proteins 0.000 abstract 3
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 abstract 3
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 238000000338 in vitro Methods 0.000 abstract 2
- 238000012360 testing method Methods 0.000 abstract 2
- 230000000903 blocking effect Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000009257 reactivity Effects 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70514—CD4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70517—CD8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/7051—T-cell receptor (TcR)-CD3 complex
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18201560 | 2018-10-19 | ||
| PCT/EP2019/078449 WO2020079264A1 (en) | 2018-10-19 | 2019-10-18 | Chimeric molecules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021004355A true MX2021004355A (es) | 2021-05-31 |
Family
ID=63965155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021004355A MX2021004355A (es) | 2018-10-19 | 2019-10-18 | Moleculas quimericas. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210324037A1 (https=) |
| EP (1) | EP3867268A1 (https=) |
| JP (1) | JP2022505107A (https=) |
| KR (1) | KR20210081345A (https=) |
| CN (1) | CN112930355A (https=) |
| AU (1) | AU2019362400A1 (https=) |
| BR (1) | BR112021007418A2 (https=) |
| CA (1) | CA3115007A1 (https=) |
| EA (1) | EA202191083A1 (https=) |
| IL (1) | IL282230A (https=) |
| MX (1) | MX2021004355A (https=) |
| WO (1) | WO2020079264A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109321569B (zh) * | 2018-10-29 | 2022-04-12 | 迈杰转化医学研究(苏州)有限公司 | 一种引物探针组合物及其应用 |
| EP4638712A2 (en) * | 2022-12-22 | 2025-10-29 | Bluesphere Bio, Inc. | Methods for identifying t cell receptors (tcrs) that bind antigens |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU765085B2 (en) * | 1998-05-11 | 2003-09-11 | Miltenyi Biotec Gmbh | Method of direct selection of antigen-specific T cells |
| ES3009756T3 (en) * | 2013-08-05 | 2025-03-31 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumors, such as lung cancer including nsclc |
| US20160177284A1 (en) * | 2014-01-27 | 2016-06-23 | Molecular Templates, Inc. | Cell-targeted molecules comprising amino-terminus proximal or amino-terminal shiga toxin a subunit effector regions |
| CN107223051B (zh) * | 2014-12-17 | 2021-09-03 | 斯坦福国际研究院 | 抗原递送系统 |
| EP3851450B1 (en) * | 2014-12-19 | 2024-11-27 | ETH Zürich | Chimeric antigen receptors and methods of use |
| CN105504018B (zh) * | 2016-01-13 | 2019-01-04 | 郑州大学 | Lag-3亲和肽n13、制备方法及其应用 |
| CN107286246B (zh) * | 2016-12-28 | 2019-12-17 | 时力生物科技（北京）有限公司 | 治疗脑胶质瘤的嵌合抗原受体修饰的树突状细胞及其制备方法 |
-
2019
- 2019-10-18 CA CA3115007A patent/CA3115007A1/en active Pending
- 2019-10-18 CN CN201980068875.6A patent/CN112930355A/zh active Pending
- 2019-10-18 BR BR112021007418-0A patent/BR112021007418A2/pt not_active Application Discontinuation
- 2019-10-18 KR KR1020217011241A patent/KR20210081345A/ko not_active Withdrawn
- 2019-10-18 MX MX2021004355A patent/MX2021004355A/es unknown
- 2019-10-18 JP JP2021521016A patent/JP2022505107A/ja active Pending
- 2019-10-18 WO PCT/EP2019/078449 patent/WO2020079264A1/en not_active Ceased
- 2019-10-18 AU AU2019362400A patent/AU2019362400A1/en not_active Abandoned
- 2019-10-18 EA EA202191083A patent/EA202191083A1/ru unknown
- 2019-10-18 EP EP19786822.7A patent/EP3867268A1/en not_active Withdrawn
- 2019-10-18 US US17/285,338 patent/US20210324037A1/en not_active Abandoned
-
2021
- 2021-04-11 IL IL282230A patent/IL282230A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL282230A (en) | 2021-05-31 |
| WO2020079264A1 (en) | 2020-04-23 |
| AU2019362400A1 (en) | 2021-04-22 |
| EP3867268A1 (en) | 2021-08-25 |
| US20210324037A1 (en) | 2021-10-21 |
| JP2022505107A (ja) | 2022-01-14 |
| EA202191083A1 (ru) | 2021-07-23 |
| BR112021007418A2 (pt) | 2021-08-10 |
| CA3115007A1 (en) | 2020-04-23 |
| CN112930355A (zh) | 2021-06-08 |
| KR20210081345A (ko) | 2021-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2300828B1 (en) | Antigen screening system | |
| EP4345453A3 (en) | High throughput epitope identification and t cell receptor specificity determination using loadable detection molecules | |
| EA202091335A1 (ru) | Ограниченные hla класса i t-клеточные рецепторы против мутантного ras | |
| CL2018000780A1 (es) | Péptidos y combinación de péptidos para el uso en la inmunoterapia contra el cáncer microcítico de pulmón y otros tipos de cáncer | |
| BR112018012826A2 (pt) | método para gerar linfócitos, para gerar um tcr e tcr específico para gage-1 | |
| MX2020004094A (es) | Metodos para administrar inmunoterapia con receptores de antigeno quimerico. | |
| CR20180490A (es) | Celulas t transfectados y receptores de linfocito t para el uso en la inmunoterapia contra el cancer | |
| PH12017500483A1 (en) | Method for the absolute qualification of naturally processed hla-restircted cancer peptides | |
| IL218447A0 (en) | Co-culture lymphoid tissue equivalent (lte) for an artificial immune system (ais) | |
| EA202090757A1 (ru) | T-КЛЕТОЧНЫЕ РЕЦЕПТОРЫ, РАСПОЗНАЮЩИЕ МУТАНТНЫЙ p53 | |
| MX2012003058A (es) | Vacunas dirigidas a celulas de langerhans. | |
| EP2534257A4 (en) | METHOD OF IDENTIFYING AND ISOLATING CELLS FOR THE EXPRESSION OF POLYPEPTIDES | |
| MX2013008471A (es) | Metodos y aparatos para la deteccion de sensibilidad al gluten y su diferenciacion de la enfermedad celiaca. | |
| Durgeau et al. | Human preprocalcitonin self-antigen generates TAP-dependent and-independent epitopes triggering optimised T-cell responses toward immune-escaped tumours | |
| MX2021004355A (es) | Moleculas quimericas. | |
| Ciabattini et al. | Characterization of the antigen-specific CD4+ T cell response induced by prime-boost strategies with CAF01 and CpG adjuvants administered by the intranasal and subcutaneous routes | |
| CY1120220T1 (el) | Μεθοδοι και κυτια για προσδιορισμο της καταστασης λοιμωξης απο φυματιωση | |
| CA2890872A1 (en) | Device and method for maintaining an air conditioner | |
| CL2017002346A1 (es) | Nuevos péptidos y nueva combinación de péptidos para el uso en la inmunoterapia contra el cáncer de páncreas y otros tipos de cáncer | |
| ZA202006223B (en) | Mammalian mhc peptide display as an epitope selection tool for vaccine design | |
| FI3380115T3 (fi) | Peptidejä piwil1:stä | |
| Caro-Gomez et al. | Phenotype of the anti-Rickettsia CD8+ T cell response suggests cellular correlates of protection for the assessment of novel antigens | |
| IN2014DN10408A (https=) | ||
| PH12019500431A1 (en) | Neutralizing anti-tetanus human monoclonal antibodies for c. tetani infection, method of obtaining said monoclonal antibodies and their use in immunotherapy for accidents susceptible to tetanus bacillus infection | |
| WO2019194360A8 (ko) | 개의 수혈 적합성 판별 방법, 및 이를 위한 키트, 단일클론항체 및 하이브리도마 세포주 |